(Q39074816)

English

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly

scientific article published on 20 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly (English)

1 reference

Europe PubMed Central

8 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

author name string

Xi'an Zhang

1

1 reference

Europe PubMed Central

8 September 2017

Lingna Huang

2

1 reference

Europe PubMed Central

8 September 2017

Yinglin Zhao

3

1 reference

Europe PubMed Central

8 September 2017

Wuhong Tan

4

1 reference

Europe PubMed Central

8 September 2017

publication date

20 October 2013

1 reference

Europe PubMed Central

8 September 2017

Acta Biochimica et Biophysica Sinica

1 reference

Europe PubMed Central

8 September 2017

45

1 reference

Europe PubMed Central

8 September 2017

12

1 reference

Europe PubMed Central

8 September 2017

995-1001

1 reference

Europe PubMed Central

8 September 2017

Targeted therapies in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Mechanisms of resistance to cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Drug transporters of platinum-based anticancer agents and their clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Real-time quantification of microRNAs by stem-loop RT-PCR

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Silencing of X-linked inhibitor of apoptosis decreases resistance to cisplatin and paclitaxel but not gemcitabine in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNAs in metabolism and metabolic diseases

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Role of microRNAs in drug-resistant ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMT113

21 January 2018

Identifiers

10.1093/ABBS/GMT113

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39074816&oldid=2167695726"